solutions

Chapter 51 - Shadows in the Gene

Two years after Gabriel took the helm of the Leo Institute, the world of biotechnology was rocked by a seismic shift that no one anticipated. A mysterious neuro-developmental condition, dubbed the Coastal Pediatric Tremor Syndrome, began emerging in clusters across the Eastern Seaboard, baffling clinicians from Johns Hopkins to Boston Children’s Hospital. Infants born with the condition suffered severe motor regression within their first six months.

At twenty-eight, Eleanor was on a brief sabbatical from the Philharmonic, staying at the cottage to compose a concerto dedicated to neonatal survivors. She was in the sunroom tuning her cello when Gabriel burst through the front door, his coat damp with sea mist, his laptop bag slung over his shoulder.

"Mom! Dad!" Gabriel called out, his voice sharp with that clinical intensity I remembered from Meline's early days.

Meline emerged from the library, her reading glasses in hand. "Gabriel? What is it? You look like you've been running on adrenaline for forty-eight hours."

"We sequenced the anomalous marker, Mom," Gabriel said, setting his laptop on the dining table and pulling up three-dimensional genetic helical models. "The syndrome isn't an environmental pathogen. It’s an epigenetic mutation triggered by an industrial neurotoxin that was dumped into the Penobscot watershed twelve years ago."

My jaw tightened. "The Penobscot watershed? That’s thirty miles north of Haven's Point. Who owned the industrial refining permits twelve years ago?"

Gabriel looked up, his hazel eyes dark with grim fury. "A shell consortium called Titan Vanguard Chemical. And before you ask, Dad—Marcus and I ran the corporate lineage through the Delaware registry this morning. Titan Vanguard was a subsidiary of Courtland Capital, liquidated right before Julian Courtland went to federal prison."

The ghost of Julian Courtland was reaching from beyond the grave once again, poisoning the very soil and water of Maine.

"How many infants are affected, Gabriel?" Meline asked, her scientific instincts overriding any lingering shock.

"Fourteen confirmed cases in Maine, twenty-two in Massachusetts," Gabriel replied. "Their neural synapses are degrading at four percent per week. Standard neuro-protectants aren't crossing the blood-brain barrier. But our Gen-6 targeted lipid nanoparticle platform... Mom, if we can synthesize a synthetic neural peptide using your old cerebellar regeneration blueprints, we can arrest the degradation within seventy-two hours."

"Then why haven't you started the bioreactors?" I asked, stepping up to the table.

Gabriel hesitated, looking at his mother with deep apprehension.

"Because the specific molecular precursor we need is an ultra-rare synthetic enzyme called Neuro-Dex 4," Gabriel explained. "The global patent for Neuro-Dex 4 doesn't belong to Vance Medical. It was bought at the Courtland bankruptcy auction eight years ago by an offshore private equity firm named Ares Biopharma."

"And who controls Ares Biopharma?" Meline asked, her voice dropping into an icy, dangerous calm.

Gabriel turned the screen toward us.

A photograph populated the display: a woman in her late forties, wearing an executive charcoal suit, standing before the federal courthouse in New York.

It was Elena Courtland.

Elena had been granted early compassionate release two years ago after serving twenty-two years of her twenty-eight-year sentence, having cooperated extensively with federal authorities to dismantle offshore criminal cartels. She had vanished into private life, legally barred from holding corporate officer positions.

May you like

"She’s out," I whispered.

"She’s out, Dad," Gabriel said. "And she holds the only key that can save these thirty-six babies."

Related Stories

Other posts